This Washington Post article details how the side effects of medication may not become apparent immediately and as a result patients should continue to consult with medical professionals over the duration of the time they are taking medication. Read the article here.
Side Effects Can Develop Even if You’ve Been Taking a Pill for a Long Time
New Clues About Why Sleep Loss is Linked to Depression, Anxiety
A new study conducted by authors from Binghamton University looked into the connection between Repetitive Negative Thinking (RNT) and a lack of sleep. Their findings show a correlation between sleep deprivation and an “inability to suppress negative stimuli.” Read more here.
LivaNova Commences Global RESTORE-LIFE Study for Treatment Resistant Depression
Livanova PLC has announced the launch and enrollment of the first patient for its observational post-market study to assess the effectiveness of its Vagus Nerve Stimulation Therapy. The study will assess the short, medium and long term impact of ‘VNS Therapy’ on those suffering from treatment resistant depression. Read the article here.
Fresh and Fit: New Research Helps Us to Understand Bipolar Disorder
Article discusses 7 findings from a recently completed study done by the University of Michigan concerning Bipolar Disorder. Read the article here.
Stanford Scientists Classify 5 Subtypes of Anxiety and Depression
A new study from Stanford researchers states at least five different types of anxiety exist, each correlated with the activation of different brain networks. Refining the broad diagnoses of depression and anxiety into more specific sub-categories will hopefully allow for more effective treatment options and better refined coping strategies. Read about it here.
Your Health: Her Depression is Treated with a Combination of Two Common Drugs
Doctors across the country are now testing a drug combination for patients with drug-resistant depression. The hope is that the new combination will inhibit the breakdown of a common anti-depressant. Read about it here.
Biotech Sage Therapeutics Skyrockets More Than 70 Percent After Depression Drug Breakthrough
Sage Therapeutics said in a release that 64 percent of patients achieved Major Depression Disorder remission using the SAGE-217 drug in the 15th day of treatment. Read the article here.
Light Therapy May Improve Symptoms of Bipolar Depression
This article in Healthline details a study, and expert reactions to its findings, in which preliminary results demonstrate that Light Therapy shows promise for treating bi-polar depression. Read it here.
12 Types Of Depression, And What You Need To Know About Each
A helpful summary of the signs, symptoms and some possible treatments for the most prevalent forms of depression. Read it here.
How To Deal With Stigmatizing Remarks About Mental Illness
In the wake of the massacre in Texas, this pertinent article looks into how President Trump’s characterization of the shooting as resulting from a “mental health problem” is part of a broader tendency to demonize mental illness in the wake of tragedies. The article lays out why such an approach is both misleading and unhelpful, while also providing some helpful advice for combatting stigmatization. Read it here.
Featured In:
Built by Staple Creative